Impressive drilling results and zinc price strength to drive ZMI higher


Published 07-SEP-2016 13:56 P.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Only a week after completing a capital raising to expand the exploration of the group’s Kildare zinc project, Zinc of Ireland (ASX: ZMI) announced on Wednesday morning that significant zinc sulphide mineralisation had been intersected at the site.

Reflecting briefly on the capital raising, it is worth noting that the placement was fully subscribed at an issue price of 2.4 cents per share in line with the company’s trading price at that time. Given ZMI is only a small speculative player, raising capital at par is a vote of confidence.

Running the ruler across today’s drilling results there are two important takeaways. Firstly, the company has only drilled three holes to date with one confirming shallow oxidised sulphides from 16 metres to 36 metres, and another intersecting 20 metres of brecciated zinc bearing sulphides from 417 metres.

Consequently, the strike rate provides confidence that the company is targeting the right areas, effectively minimising costs and opening up the prospect of further exploration success.

Equally important though is the fact that the mineralisation intersected at 417 metres had not previously been tested, opening up a new target outside the historical drilling data the company had been using to shape its exploration program.

Management described the mineralisation intersected as indicative of Mississippi Valley Type (MVT) which is the target style of the Kildare project.

ZMI said it will separately announce its plans with regards to follow-up work in this area, but it did not indicate the likely timing of assay results from recent drilling.

Given historical drilling results had delineated impressive grades including 48 metres grading 12.2% zinc and lead from 14 metres, the lab results could prove interesting.

The zinc price outlook still appears strong with analysts at Macquarie Wealth Management highlighting last week that the commodity had hit a fresh 15 month high US$2370 per tonne.

Importantly, the broker determined that China-based buying appeared to be driving the price higher. It noted that recent London Metals Exchange price activity moves had shown a burst in trading volumes during the Shanghai Futures Exchange trading hours with almost a quarter of lots traded before 8 AM London time over the two week period when the price spiked.

According to Macquarie, Shanghai Futures Exchange volumes and open interest have also stepped up with a definite long skew. The market closely follows China’s trading activity in base metals because of its position as a global manufacturing powerhouse, suggesting the need to monitor the trends highlighted by Macquarie.

In summing up the broker said, “We can only conclude that zinc has become the flavour of the month in China after more hesitancy seemed to be apparent over the midsummer.”

The significance of these developments for ZMI is that positive momentum in the price of zinc could run in parallel with upbeat exploration news providing significant tailwinds for the company’s share price.

However, it should be noted that past performance of ZMI’s share price and broker projections are not an indication of future share price performance and investors should seek professional financial advice in making investment decisions.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free